Interventional/Structural Cardiologist @DoylestownHlth, former @yalecardiology structural fellow, @hopkinsheart IC fellow, @TJheartfellows. Tweets are my own.
Complete revasc (CR) in pts with non-shock STEMI and multivessel ds. reduces MACE. But is the best timing for non-culprit lsn PCI immediate (during primary PCI) or staged? Our new meta-analysis publ in Circ CV Interv suggests immediate CR may increase mortality, same as in shock.
Thrilled to welcome the Pascal platform to our structural heart program @DoylestownHlth@PennMedicine Expanding our toolkit means more options, more precision & more patients getting the care they deserve. Proud of the excellent outcomes we continue to achieve with every M-TEER🫀
After TAVI, invasively measured transvalvular gradients—but not echocardiography-derived gradients— were associated with mortality up to 2 years. Echocardiography systematically overestimated gradients, particularly with balloon-expandable valves. Read more in our #EIJBestOf 👇
#CardioTwitter #TAVI
🔗https://t.co/Nb5dAvZLpB
@RikAdrMD@verhemel@Rjnuis@JoostDaemen@drnvanmieghem
LAA closure – is peri-device patency a problem to address? This pooled meta-analysis reveals that residual LAA patency detected by cardiac CT post-#LAAO significantly raises thromboembolic risk. https://t.co/6nIr7ozEXl
#JACCIMG@KasperKorsholm@XanderJacquemyn@IbrahimSultanMD
#DAPT after valve-in-valve #TAVR may be associated with a lower 1-yr incidence of stroke. In contrast, no significant difference was observed for other major ischemic and bleeding outcomes or for premature valve deterioration. https://t.co/2QUhtuN2H8 #JACCINT@saia_francesco
@NEJM Impressive #AI#infographic that can be generated with a reasonable prompt, and easily improved to incl other details e.g. exclusions no left main, no bifurcation in #TARGETFIRST https://t.co/qVmuAjhBPD
Often get my new fellows thinking PCWP 15 is a hard and fast. For anyone who haven't read @Brian_Houston12 @RyanTedfordMD https://t.co/29QX5DL8iS - highly recommend
NOTION-2 continues to show a major consideration of PPM in #SAVR vs #TAVR. Something to consider in "borderline" cases & particularly small annuli. #TAVR maybe getting better w/ bicuspid but numerically at least significant outcome difference to consider https://t.co/zjETfKcSdI
Do female patients respond differently than males? Higher 2-year MACE after sirolimus-coated balloon angioplasty for female patients with in-stent restenosis. A hypothesis generating research letter @Dr.LucaTesta @leoneppmd@AGrecoMD@Dari08s
https://t.co/oSMRqCSJo1
#AorticValve calcification isn't just aging—it's a complex disease! #JACCAsia review dives into new research on inflammation, lipid deposits & fibrosis, plus promising therapies like lipid-lowering drugs & next-gen valve designs. A step toward better care! https://t.co/dplwrF26jR
Late-breaker at #ACC2025: Dr. Joo-Yong Hahn presented the SMART-CHOICE 3 trial, showing superior efficacy and comparable safety of clopidogrel as long-term maintenance monotherapy in high-risk pts compared to aspirin. Slides here: https://t.co/XLZy7c4e6j
#ACC25#CircSimPub Two-year follow-up results of TRILUMINATE trial indicate significant reduction in tricuspid regurgitation severity & decreased HF hospitalization rates with tricuspid TEER compared to medical therapy. https://t.co/H9ef9xgLtt #AHAJournals@hahn_rt@tavrkapadia
In a late-breaking clinical trial, Drs. @johnkforrest, @MReardon19, et al report that low-risk patients with AS treated with #TAVR had similar rates of mortality and #stroke at 5 years compared to those treated with surgery https://t.co/qdOAoWLF1k
#JACC#ACC25#vhdAS#SAVR
Maintaining radial patency after CABG Surgery: the Randomized ASRAB -Pilot Study. Lower graft failure with nicorandil or isosorbide mononitrate compared to diltiazem #AHAJournals https://t.co/vu1gwtwZID
In patients with #AFib and stable #cvCAD, OAC monotherapy, compared with OAC plus SAPT, was not associated with a statistically significant increased risk of ischemic events but resulted in a significantly reduced risk of bleeding. https://t.co/vOen1sLSZX
#JACC#cvCoag@bbikdeli